Drug versus placebo randomized controlled trials in neonates: A review of ClinicalTrials.gov registry.

Drug versus placebo randomized controlled trials in neonates: A review of ClinicalTrials.gov registry.

BACKGROUND:Despite specific initiatives and identified needs, most neonatal drugs are still used off-label, with variable dosage administrations and schedules. In high risk preterm and term neonates, drug evaluation is challenging and randomized controlled trials (RCT) are difficult to conduct and e...

Full description

Bibliographic Details
Main Authors:	Emilie Desselas, Claudia Pansieri, Stephanie Leroux, Maurizio Bonati, Evelyne Jacqz-Aigrain
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5305102?pdf=render

Similar Items

Computerized monitoring of COVID-19 trials, studies and registries in ClinicalTrials.gov registry
by: Craig S. Mayer, et al.
Published: (2020-10-01)

Problematic trial detection in ClinicalTrials.gov
by: Chris Hartgerink, et al.
Published: (2015-12-01)

Registration of phase 3 crossover trials on ClinicalTrials.gov
by: Lijuan Zeng, et al.
Published: (2020-07-01)

Obstacles to the reuse of study metadata in ClinicalTrials.gov
by: Laura Miron, et al.
Published: (2020-12-01)

Some data quality issues at ClinicalTrials.gov
by: Neha Chaturvedi, et al.
Published: (2019-06-01)

The Egyptian clinical trials’ registry profile: Analysis of three trial registries (International Clinical Trials Registry Platform, Pan-African Clinical Trials Registry and clinicaltrials.gov)
by: Ahmed A. Zeeneldin, et al.
Published: (2016-01-01)

Quality and Publication of Emergency Medicine Trials Registered in ClinicalTrials.gov
by: Lisa Calvocoressi, et al.
Published: (2020-01-01)

Trends in mental health clinical research: Characterizing the ClinicalTrials.gov registry from 2007-2018.
by: Joshua R Wortzel, et al.
Published: (2020-01-01)

Comprehensive Survey of Clinical Trials Registration for Melanoma Immunotherapy in the ClinicalTrials.gov
by: Yan-Bo Wang, et al.
Published: (2020-01-01)

Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals.
by: Carolina Riveros, et al.
Published: (2013-12-01)

The Characteristics of TCM Clinical Trials: A Systematic Review of ClinicalTrials.gov
by: Junchao Chen, et al.
Published: (2017-01-01)

Comparative effectiveness research: an empirical study of trials registered in ClinicalTrials.gov.
by: Florence T Bourgeois, et al.
Published: (2012-01-01)

Comparative Effectiveness Research: An Empirical Study of Trials Registered in ClinicalTrials.gov
by: Bourgeois, Florence T., et al.
Published: (2012)

Comparison of published orthopaedic trauma trials following registration in Clinicaltrials.gov
by: Gandhi Rajiv, et al.
Published: (2011-12-01)

Results and outcome reporting In ClinicalTrials.gov, what makes it happen?
by: Olga Kirillova
Published: (2012-01-01)

The state of infectious diseases clinical trials: a systematic review of ClinicalTrials.gov.
by: Neela D Goswami, et al.
Published: (2013-01-01)

Assessing the Impact of the NIH CTSA Program on Clinical Trials Registered With ClinicalTrials.gov
by: Arthur Berg
Published: (2020-07-01)

Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis.
by: Joseph S Ross, et al.
Published: (2009-09-01)

An Analysis of Sponsors/Collaborators of 69,160 Drug Trials Registered with ClinicalTrials.gov.
by: Shruthi Muralidharan Keezhupalat, et al.
Published: (2016-01-01)

Locating Organizations and Their Methods in Registrations of Clinical Migraine Trials: Analysis of ClinicalTrials.gov
by: Pengfei Zhang, et al.
Published: (2021-10-01)

Comprehensive Analysis of Clinical Trials Registration for Lupus Nephritis Therapy on ClinicalTrials.gov
by: Yanfang Gao, et al.
Published: (2021-06-01)

Characteristic and Early Discontinuation of Obsessive-Compulsive Disorder Trials Registered on ClinicalTrials.gov
by: Shanxia Luo, et al.
Published: (2021-07-01)

Differences in Investigator-Initiated Trials between Japan and Other Countries: Analyses of Clinical Trials Sponsored by Academia and Government in the ClinicalTrials.gov Registry and in the Three Japanese Registries.
by: Tatsuya Ito
Published: (2016-01-01)

Patient preferences when searching for clinical trials and adherence of study records to ClinicalTrials.gov guidance in key registry data fields.
by: Thomas M Schindler, et al.
Published: (2020-01-01)

Transparency in ovarian cancer clinical trial results: ClinicalTrials.gov versus PubMed, Embase and Google scholar
by: Anna Roberto, et al.
Published: (2018-04-01)

Clinical trial reporting performance of thirty UK universities on ClinicalTrials.gov—evaluation of a new tracking tool for the US clinical trial registry
by: Sarai Mirjam Keestra, et al.
Published: (2021-06-01)

Primed to comply: Individual participant data sharing statements on ClinicalTrials.gov.
by: Emily E Statham, et al.
Published: (2020-01-01)

Characteristics of COVID-19 clinical trials registered with ClinicalTrials.gov: cross-sectional analysis
by: Timothy F Platts-Mills, et al.
Published: (2020-09-01)

Linking ClinicalTrials.gov and PubMed to track results of interventional human clinical trials.
by: Vojtech Huser, et al.
Published: (2013-01-01)

Clinical trials involving positron emission tomography and prostate cancer: an analysis of the ClinicalTrials.gov database
by: Nikola Cihoric, et al.
Published: (2018-06-01)

What happens to intimate partner violence studies registered on clinicaltrials.gov? A systematic review of a clinical trials registry
by: Kim Madden, et al.
Published: (2019-05-01)

An Italian Registry on Risk Factors for Venous Thromboembolism in Blood Donors Clinicaltrials.Gov: Nct03282747
by: Elvira Grandone, et al.
Published: (2018-07-01)

Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: one decade after FDAAA
by: Ramtin Talebi, et al.
Published: (2020-07-01)

ClinicalTrials.gov as a data source for semi-automated point-of-care trial eligibility screening.
by: Pascal B Pfiffner, et al.
Published: (2014-01-01)

The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov
by: Y Que, et al.
Published: (2018-12-01)

Characteristics of Neuropsychiatric Mobile Health Trials: Cross-Sectional Analysis of Studies Registered on ClinicalTrials.gov
by: Minen, Mia Tova, et al.
Published: (2020-08-01)

Safety and efficacy of Gammaplex® in idiopathic thrombocytopenic purpura (ClinicalTrials.gov--NCT00504075).
by: Clive H Dash, et al.
Published: (2014-01-01)

The database for aggregate analysis of ClinicalTrials.gov (AACT) and subsequent regrouping by clinical specialty.
by: Asba Tasneem, et al.
Published: (2012-01-01)

Long-Term Collaboration Network Based on ClinicalTrials.gov Database in the Pharmaceutical Industry
by: Heyoung Yang, et al.
Published: (2018-01-01)

Systematic drug repositioning through mining adverse event data in ClinicalTrials.gov
by: Eric Wen Su, et al.
Published: (2017-03-01)